Return to the Faculty List

Kenneth Freedland, PhD

Current Position
Professor of Psychiatry

Education and Training
1975 B.S. Psychology, University of Oregon
1979 M.A. Clinical Psychology, Univ. of Hawaii
1982 Ph.D. Clinical Psychology, Univ. of Hawaii

Major Awards
President, Academy of Behavioral Medicine Research (2008-2009)
Distinguished Service Award, Society of Behavioral Medicine (2010)

Areas of Clinical Interest
Depression, stress, and heart disease
Behavioral trial methodology

Areas of Research Interests
I am currently conducting a study of depression as a risk factor for multiple hospital readmissions in patients with heart failure, as well as collaborating on two randomized trials of interventions for depression in cardiac patients.

Some of my other recent work focuses on methodological aspects of behavioral intervention research.

Key Publications
Carney RM, Freedland KE, Steinmeyer B, Blumenthal JA, Berkman LF, Watkins LL, Freedland KE, Mohr DC, Davidson KW, Schwartz JE. Usual and unusual care: existing practice control groups in randomized controlled trials of behavioral
interventions. Psychosom Med. 2011 May;73(4):323-35.  Full Article ->

Freedland KE, Carney RM, Rich MW. Effect of depression on prognosis in heart failure. Heart Fail Clin. 2011 Jan;7(1):11-21.  Full Article ->

Freedland KE, Skala JA, Carney RM, Rubin EH, Lustman PJ, Dávila-Román VG,
Steinmeyer BC, Hogue CW Jr. Treatment of depression after coronary artery bypass
surgery: a randomized controlled trial. Arch Gen Psychiatry. 2009 Apr;66(4):387-96.  Full Article ->

Freedland KE, Carney RM (2013 May 15). Depression as a risk factor for adverse outcomes in coronary heart disease. BMC Med. 11131.  Full Article ->

Lichtman JH, Froelicher ES, Blumenthal JA, Carney RM, Doering LV, Frasure-Smith N, Freedland KE, Jaffe AS, Leifheit-Limson EC, Sheps DS, Vaccarino V, Wulsin L, American Heart Association Statistics Committee of the Council on Epidemiology and Prevention and the Council on Cardiovascular and Stroke Nursing (2014 Mar 25). Depression as a risk factor for poor prognosis among patients with acute coronary syndrome: systematic review and recommendations: a scientific statement from the American Heart Association. Circulation. 129(12): 1350-69.  Full Article ->

Carney RM, Freedland KE, Rubin EH, Rich MW, Steinmeyer BC, Harris WS. Omega-3
augmentation of sertraline in treatment of depression in patients with coronary
heart disease: a randomized controlled trial. JAMA. 2009 Oct 21;302(15):1651-7.  Full Article ->

Funded Research Projects
NHLBI(Key Personnel):Omega-3 for Depression and Other Cardiac Risk Factors
NHLBI(PI):Depression and Rehospitalization in Patients with Heart Failure
AHRQ(Key Personnel):Randomized Controlled Trial of Screening for Depression in Cardiac Outpatients